SCHEMBL7025980

SCHEMBL7025980

OC[C@H]1O[C@@H](n2cnc3c(-c4ccc[nH]4)ncnc32)[C@@H](O)[C@@H]1O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC29A1 Q99808 6/20 0.61
MAPK1 P28482 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
ADORA3 P0DMS8 2/20 0.61
STAT6 P42226 2/20 0.61
DPP4 P27487 1/20 0.61
MEN1 O00255 1/20 0.61
SLC28A1 O00337 1/20 0.61
MAP3K7 O43318 1/20 0.61
SLC28A2 O43868 1/20 0.61
GAPDH P04406 1/20 0.61
ADORA2A P29274 1/20 0.61
ADORA2B P29275 1/20 0.61
ADORA1 P30542 1/20 0.61
PI4KA P42356 1/20 0.61
KMT2A Q03164 1/20 0.61
PI4K2B Q8TCG2 1/20 0.61
DOT1L Q8TEK3 1/20 0.61
PI4K2A Q9BTU6 1/20 0.61
SLC28A3 Q9HAS3 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7025315 1.00 SLC29A1 (0.61) SLC29A1MAPK1SMN1; SMN2ADORA3STAT6
SCHEMBL7018814 1.00 SLC29A1 (0.61) SLC29A1MAPK1SMN1; SMN2ADORA3STAT6
SCHEMBL314104 0.83 ADK (0.68) ADK
SCHEMBL6423141 0.83 DNPH1 (0.71) SLC29A1MAPK1SMN1; SMN2ADORA3STAT6
SCHEMBL6758946 0.83 DNPH1 (0.71) SLC29A1MAPK1SMN1; SMN2ADORA3STAT6
SCHEMBL7026258 0.82 SLC29A1 (0.50) SLC29A1MAPK1SMN1; SMN2ADORA3STAT6
SCHEMBL7033888 0.81 ADK (0.74) SLC29A1MAPK1SMN1; SMN2ADORA3STAT6
SCHEMBL6760662 0.81 DNPH1 (0.69) SLC29A1MAPK1SMN1; SMN2ADORA3STAT6
SCHEMBL10161595 0.81 ADK (0.68) SLC29A1ADK
SCHEMBL10131409 0.81 ADK (0.68) SLC29A1ADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002018404-A9 NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C HOFFMANN LA ROCHE (CH) 2003-10-02 WO disclosed
EP-1315736-A2 NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C F. HOFFMANN-LA ROCHE AG (CH) 2003-06-04 EP disclosed
WO-2002018404-A2 NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C F. HOFFMANN-LA ROCHE AG (CH) 2002-03-07 WO disclosed